Subcutaneous Catabolism of Peptide Therapeutics: Bioanalytical Approaches and ADME Considerations

Many peptide drugs such as insulin and glucagon-like peptide (GLP-1) analogues are successfully administered subcutaneously (SC). Following SC injection, peptides may undergo catabolism in the SC compartment before entering systemic circulation, which could compromise their bioavailability and in turn affect their efficacy.This review will discuss how both technology and strategy have evolved over the past years to further elucidate peptide SC catabolism.Modern bioanalytical technologies (particularly liquid chromatography-high-resolution mass spectrometry) and bioinformatics platforms for data mining has prompted the development of in silico, in vitro and in vivo tools for characterizing peptide SC catabolism to rapidly address proteolytic liabilities and, ultimately, guide the design of peptides with improved SC bioavailability.More predictive models able to recapitulate the interplay between SC catabolism and other factors driving SC absorption are highly desirable to improve in vitro/in vivo correlations.We envision the routine incorporation of in vitro and in vivo SC catabolism studies in ADME screening funnels to develop more effective peptide drugs for SC delivery.

Separation and degradation detection of nanogram-per-litre concentrations of radiolabelled steroid hormones using combined liquid chromatography and flow scintillation analysis

Detection of micropollutants such as steroid hormones occurring in the aquatic environment at concentrations between ng/L and µg/L remains a major challenge, in particular when treatment efficiency is to be evaluated. Steroid hormones are typically analysed using mass-spectrometry methods, requiring pre-concentration and/or derivatisation procedures to achieve required detection limits. Free of sample preparation steps, the use of radiolabelled contaminants with liquid scintillation counting is limited to single-compound systems and require a separation of hormone mixtures before detection. In this work, a method was developed coupling ultra-high-pressure liquid chromatography (UHPLC) with flow scintillation analysis (FSA) for separation and detection of radiolabelled estrone, 17ß-estradiol, testosterone and progesterone. Adjustment of the flow rate of scintillation liquid and UHPLC mobile phase, gradient time, column temperature, and injection volume allowed the separation of steroid hormones and degradation products. The limit-of-detection (LOD = 1.5–2.4 ng/L) and limit-of-quantification (LOQ = 3.4–4.3 ng/L) for steroid hormones were comparable with the current state-of-the-art technique (LC-MS/MS) for non-derivatised compounds. Although the method cannot be applied to real water samples (unless spiked with radiotracers), it serves as a useful tool for the development of water treatment technologies at laboratory scale as demonstrated via: i) adsorption on polymer-based spherical activated carbon, ii) retention in nanofiltration, iii) photodegradation using a photocatalytic membrane.

Radisotopic characterization as an analytical tool: current status, limitations and future challenges

In this review, we describe the growth of current state-of-the-art applications that rely on the ‘online’ analysis of radiolabeled samples, focus on the nature of the most common measurement techniques and provide some insight into the potential future developments of this powerful analytical tool. In particular, this review will concentrate on two common online analysis methods that utilize radioisotope detection and analysis systems coupled to chromatographic separations: radio-GC and radio-HPLC. The different sample conditions call for different approaches to the method of radiodetection in order to optimize the sensitivity and chromatographic resolution in each case. These methods are also compared with alternative analytical techniques, including accelerator MS and ‘offline’ counting.